Evidence map›Paper›PMID 24468999›Full record

ArticleAIDS (London, England)2014

Retention in care under universal antiretroviral therapy for HIV-infected pregnant and breastfeeding women ('Option B+') in Malawi.

Lyson Tenthani, Andreas D Haas, Hannock Tweya, Andreas Jahn, Joep J van Oosterhout, Frank Chimbwandira, Zengani Chirwa, Wingston Ng'ambi, Alan Bakali, Sam Phiri and 5 more

Registry-linked trialAbstract read
In one paragraph

Article in AIDS (London, England), 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT02459678 (ART Readiness in HIV-infected Pregnant Women), which is not on this map. Cited by 251 papers, 6 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
251citing papers in PubMed, 6 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT02459678 nacompletednot on this mapstarted 2015, after this paper: background citation

ART Readiness in HIV-infected Pregnant Women: From Formative Qualitative Research to Individual Randomized Trial

TypeinterventionalSponsorUniversity of North Carolina, Chapel HillRan2015 to 2018Enrolled454ConditionsHuman Immunodeficiency VirusArmsEnhanced Adherence Package, Standard of Care
3 · Its place in the literature

Who cites it

251 citing papers in PubMed, 6 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Pooled it
  7. Trial
  8. Trial
  9. Trial
  10. Trial
  11. Trial
  12. Trial
  13. Trial
  14. Trial
  15. Trial
  16. Trial
  17. Trial
  18. Trial
  19. Trial
  20. Trial

191 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

15 authors.

Lyson Tenthani *Department of HIV and AIDS, Ministry of Health, Lilongwe, Malawi.
Andreas D Haas *Institute of Social and Preventive Medicine, University of Bern, Switzerland.
Hannock TweyaInstitute of Social and Preventive Medicine, University of Bern, Switzerland.
Andreas JahnDepartment of HIV and AIDS, Ministry of Health, Lilongwe, Malawi.
Joep J van OosterhoutDignitas International, Zomba, Malawi.
Frank ChimbwandiraDepartment of HIV and AIDS, Ministry of Health, Lilongwe, Malawi.
Zengani ChirwaDepartment of HIV and AIDS, Ministry of Health, Lilongwe, Malawi.
Wingston Ng'ambiLighthouse Trust Clinic, Lilongwe, Malawi.
Alan BakaliBaobab Trust, Lilongwe, Malawi.
Sam PhiriLighthouse Trust Clinic, Lilongwe, Malawi.
Landon MyerCentre for Infectious Disease Epidemiology and Research, School of Public Health & Family Medicine, University of Cape Town, South Africa.
Fabio ValeriInstitute of Social and Preventive Medicine, University of Bern, Switzerland.
Marcel ZwahlenInstitute of Social and Preventive Medicine, University of Bern, Switzerland.
Gilles WandelerInstitute of Social and Preventive Medicine, University of Bern, Switzerland.
Olivia Keiser *Institute of Social and Preventive Medicine, University of Bern, Switzerland.

Funding

Observational Antiretroviral Studies In Southern Africa (OASIS) CollaborationU01AI069924 · NIAID · UNIVERSITAT BERN · PI Cleophas Chimbetete, Mary-Ann Davies · 2006 to 2026
$55.9M
NIAID NIH HHS U01 AI069924PHS HHS AID-OAA-A-11-00012
6 · The paper itself

Abstract

objectiveTo explore the levels and determinants of loss to follow-up (LTF) under universal lifelong antiretroviral therapy (ART) for pregnant and breastfeeding women ('Option B+') in Malawi. DESIGN, SETTING, AND

participantsWe examined retention in care, from the date of ART initiation up to 6 months, for women in the Option B+ program. We analysed nationwide facility-level data on women who started ART at 540 facilities (n = 21,939), as well as individual-level data on patients who started ART at 19 large facilities (n = 11,534).

resultsOf the women who started ART under Option B+ (n = 21,939), 17% appeared to be lost to follow-up 6 months after ART initiation. Most losses occurred in the first 3 months of therapy. Option B+ patients who started therapy during pregnancy were five times more likely than women who started ART in WHO stage 3/4 or with a CD4 cell count 350 cells/μl or less, to never return after their initial clinic visit [odds ratio (OR) 5.0, 95% confidence interval (CI) 4.2-6.1]. Option B+ patients who started therapy while breastfeeding were twice as likely to miss their first follow-up visit (OR 2.2, 95% CI 1.8-2.8). LTF was highest in pregnant Option B+ patients who began ART at large clinics on the day they were diagnosed with HIV. LTF varied considerably between facilities, ranging from 0 to 58%.

conclusionDecreasing LTF will improve the effectiveness of the Option B+ approach. Tailored interventions, like community or family-based models of care could improve its effectiveness.

Indexed as

Antiretroviral Therapy, Highly ActiveBreast FeedingLost to Follow-UpAdolescentAdultAnti-Retroviral AgentsFemaleHealth Services ResearchHIV InfectionsHumansMalawiMiddle AgedPregnancyPregnancy Complications, InfectiousYoung AdultAnti-Retroviral Agents

Identifiers

PMID24468999
PMCPMC4009400

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.